Home BioGeometry

BioGeometry

In operation
Strategic Financing
Large Molecule Drug Developer

Basic Information

BioGeometry was founded in 2021 by Dr. Jian Tang, an associate professor and tenured professor at Mila, the Algorithm Institute of the University of Montreal, Canada. It is dedicated to developing next-generation artificial intelligence technologies such as geometric deep learning and deep generative models for the research and development of macromolecular drugs (antibodies, enzymes, cell therapy, gene therapy, vaccine design, etc.).
BioGeometry
Beijing,China
15~50 people
December 22, 2021
pr@biogeom.com